<?xml version="1.0" encoding="UTF-8"?>
<p>However, until we have a good understanding of what the denominator is, we will not be able to properly assess the risk of this new coronavirus for public health. During April, the scientific community finally began to receive the first reports from the Netherlands, Denmark, Italy, Iceland, and California [
 <xref rid="R19" ref-type="bibr">19</xref>,
 <xref rid="R20" ref-type="bibr">20</xref>]. Researchers at all of these sites have finally begun to search for antibodies in the blood that indicate that people have become infected with COVID-19 and have become immune to the virus without even knowing it. When such a survey is conducted on a sample that should be representative of the population, we say that we are carrying out the studies of so-called “seroprevalence”.
</p>
